Cardiovascular Effects of GLP-1 RA in Kidney Failure
About this episode
Drs. Benjamin Catanese and Daniel Edmonston discuss their study on cardiovascular outcomes in kidney failure patients using GLP-1 receptor agonists compared to other medications.
Drs. Benjamin Catanese and Daniel Edmonston discuss their study, "Cardiovascular Outcomes among New Users of GLP-1 Receptor Agonists Compared with DPP-4 Inhibitors and Sulfonylureas in Kidney Failure," with JASN Deputy Editor Manjula Kurella Tamura.
More episodes of Journal of the American Society of Nephrology (JASN)
- Barriers to Kidney Transplantation in the United States
- ASN Kidney Translation Series: ASN Kidney Health Guidance on the Cardiovascular-Kidney-Metabolic Syndrome
- APOL1 at the Plasma Membrane and Cytotoxicity
- ASN Kidney Translation Series: Cardiovascular-Kidney-Metabolic (CKM) Syndrome Advances
- Temporal, Cell-Specific Angiopoietin-2 in CKD
- ASN Kidney Translation Series: Artificial Intelligence in Nephrology
Explore listener stats, chart rankings, contacts and more on the Journal of the American Society of Nephrology (JASN) podcast page.